Syndax Announces Additional Positive Data for Revuforj® (revumenib) from AUGMENT-101 Trial in Relapsed or Refractory mNPM1 AML and BEAT AML Frontline Combination Trial
– Subgroup analyses from Ph 2 protocol-defined R/R mNPM1 AML efficacy population (N=64) show responses across all major subgroups, including heavily pretreated patients – – 26% CR+CRh (20/77) and 48% ORR (37/77) in all enrolled patients who met the efficacy evaluable criteria in Ph 2 R/R mNPM
Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
20,000-square-foot site increases Endo’s sterile injectable production capacity This marks the site’s first U.S. FDA approval Endo is investing and innovating in its Injectable Solutions business MALVERN, Pa., Dec. 9, 2024 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) announced today tha
Mason Capital Management-Led Consortium Completes Acquisition of CB&I
All-cash equity transaction positions CB&I for long-term growth THE WOODLANDS, Texas, Dec. 9, 2024 /PRNewswire/ — CB&I, the world’s foremost designer and builder of storage facilities, tanks and terminals for energy and industrial markets, today announced the completion of its ac
PAINTEQ SECURES GROUNDBREAKING PATENT FOR LINQ® TECHNOLOGY, ADVANCING PRECISION AND EFFICIENCY IN SI JOINT FUSION
New Patent Adds Significant Protections to PainTEQ’s Instrumentation and Reinforces Its Leadership Position in Minimally Invasive SI Joint Dysfunction Treatment TAMPA, Fla., Dec. 9, 2024 /PRNewswire/ — PainTEQ, a leader in minimally invasive sacroiliac (SI) joint dysfunction treatment,
American bespoke Coaching and Psychiatry practice The Open Sea Institute showcased in new book to celebrate 120 years of Rolls-Royce
LONDON, Dec. 9, 2024 /PRNewswire/ — The name Rolls-Royce has always been synonymous with the very best in luxury and motoring. It is only appropriate, then, that one of the oldest and most prestigious car clubs, the International Club for Rolls-Royce and Bentley Enthusiasts (or the RREC, as it
Solu Therapeutics Presents Positive Preclinical Data on STX-0712 for Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting
STX-0712 showed robust activity against CCR2-positive monocytes in CMML and AML patient samples BOSTON, Dec. 9, 2024 /PRNewswire/ — Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today annou
Chandler couple opens Caring Senior Service to bring trusted support and companionship to local families
The new business owners will bring passionate, non-medical services to residents aging in place in the Phoenix metropolitan area CHANDLER, Ariz., Dec. 9, 2024 /PRNewswire/ — Caring Senior Service, a non-medical, personalized home care services company, announced today the opening of a new loc
Women in HVACR records largest endowment fund donation to date
Donations to be used as a resource to support the growth of women in HVACR careers ENGLEWOOD, Colo., Dec. 9, 2024 /PRNewswire/ — Women in HVACR (WHVACR), a nonprofit organization dedicated to empowering women in the heating, ventilation, air conditioning and refrigeration trades, announced a $
VERSABANK TRANSITIONS CORE TEAM RESPONSIBLE FOR CANADIAN RECEIVABLE PURCHASE PROGRAM SUCCESS TO LEAD US OPPORTUNITY
LONDON, ON, Dec. 9, 2024 /PRNewswire/ – VersaBank (TSX: VBNK) (NASDAQ: VBNK), a North American leader in business-to-business digital banking, as well as technology solutions for cybersecurity, today announced the transition of key members of the executive team responsible for the success of
EARTHDAY.ORG RELEASES THE FIRST-OF-ITS-KIND LIVE TRACKER: MONITORING THE STATUS OF CLIMATE EDUCATION IN NATIONALLY DETERMINED CONTRIBUTIONS (NDCs) ACROSS THE WORLD
WASHINGTON, Dec. 9, 2024 /PRNewswire/ — EARTHDAY.ORG, the global leader in Earth Day advocacy, observed by over one billion people each year on April 22, is proud to announce the launch of its climate education NDC Tracker —a groundbreaking tool designed to track and analyze the status of cl
